Xilio Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Xilio Therapeutics, Inc. (XLO) reported Increase (Decrease) in Prepaid Expense and Other Assets of $581.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-12
- Xilio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$624.00K.
- Xilio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $1.21M.
- Xilio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$495.00K, a 118.00% decline year-over-year.
- Xilio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $500.00K.
- Xilio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$3.08M, a 413.46% decline from fiscal 2024.
- Xilio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $981.00K.
- Xilio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$688.00K.
- Xilio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$344.00K, a 110.97% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$624.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $581.00K 10-Q · filed 2026-08-12 | $86.00K derived: sum of 3 quarters · filed 2026-08-12 | $586.00K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $1.21M 10-Q · filed 2026-05-12 | $710.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.21M derived: sum of 3 quarters · filed 2026-05-12 | -$906.00K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -$495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $5.00K derived: sum of 2 quarters · filed 2026-03-23 | -$2.11M derived: sum of 3 quarters · filed 2026-08-12 | -$3.08M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.62M derived: sum of 2 quarters · filed 2026-08-12 | -$2.58M 10-Q · filed 2025-11-13 | $170.00K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | -$2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$3.08M 10-Q · filed 2026-08-12 | -$330.00K derived: sum of 3 quarters · filed 2026-08-12 | -$1.48M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | -$964.00K 10-Q · filed 2026-05-12 | -$816.00K 10-Q · filed 2025-05-08 | $1.79M derived: sum of 2 quarters · filed 2026-05-12 | $640.00K derived: sum of 3 quarters · filed 2026-05-12 | -$1.76M derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $1.60M derived: sum of 2 quarters · filed 2026-03-23 | -$801.00K derived: sum of 3 quarters · filed 2026-03-23 | $981.00K 10-K · filed 2026-03-23 | $1.52M 10-K · filed 2025-03-11 | |||
| 2024-09-30 | -$1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$3.55M derived: sum of 2 quarters · filed 2025-11-13 | -$1.77M 10-Q · filed 2025-11-13 | -$1.37M 10-Q · filed 2024-11-07 | -$3.05M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$623.00K 10-Q · filed 2025-08-14 | -$364.00K 10-Q · filed 2024-08-08 | -$1.91M derived: sum of 3 quarters · filed 2025-08-14 | -$242.00K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $1.78M 10-Q · filed 2025-05-08 | $497.00K derived: sum of 2 quarters · filed 2025-05-08 | $2.16M derived: sum of 3 quarters · filed 2025-05-08 | $1.50M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $381.00K derived: sum of 2 quarters · filed 2025-03-11 | -$282.00K derived: sum of 3 quarters · filed 2025-03-11 | -$688.00K 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.00M derived: sum of 2 quarters · filed 2024-11-07 | $597.00K 10-Q · filed 2024-11-07 | $1.54M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$663.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.07M 10-Q · filed 2024-08-08 | -$130.00K derived: sum of 3 quarters · filed 2024-08-08 | -$556.00K derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$406.00K 10-Q · filed 2024-05-14 | $533.00K derived: sum of 2 quarters · filed 2024-05-14 | $107.00K derived: sum of 3 quarters · filed 2024-05-14 | -$414.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $939.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $513.00K derived: sum of 2 quarters · filed 2024-04-01 | -$8.00K derived: sum of 3 quarters · filed 2024-04-01 | -$344.00K 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$426.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$947.00K derived: sum of 2 quarters · filed 2023-11-09 | -$1.28M 10-Q · filed 2023-11-09 | -$1.74M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$521.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$857.00K 10-Q · filed 2023-08-14 | -$1.32M derived: sum of 3 quarters · filed 2023-08-14 | $881.00K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$336.00K 10-Q · filed 2023-05-09 | -$797.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.40M derived: sum of 3 quarters · filed 2023-05-09 | $2.95M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$461.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $1.74M derived: sum of 2 quarters · filed 2023-03-02 | $3.29M derived: sum of 3 quarters · filed 2023-03-02 | $3.14M 10-K · filed 2023-03-02 | ||||
| 2021-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.75M derived: sum of 2 quarters · filed 2022-11-09 | $3.60M 10-Q · filed 2022-11-09 | $4.12M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.40M 10-Q · filed 2022-08-09 | $1.92M derived: sum of 3 quarters · filed 2022-08-09 | |||||
| 2021-03-31 | -$153.00K 10-Q · filed 2022-05-12 | $367.00K derived: sum of 2 quarters · filed 2022-05-12 | ||||||
| 2020-12-31 | $520.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$2.28M 10-K · filed 2022-03-01 | ||||||
| 2020-09-30 | -$2.80M 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 |